个性化新抗原导向黑色素瘤治疗
Karam Khaddour1,2,3, Elizabeth I Buchbinder4,5,6
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. karam_khaddour@dfci.harvard.edu.
American journal of clinical dermatology
|January 28, 2025
概括
个性化新抗原疫苗利用患者的免疫系统来向黑色素瘤. 这种个性化疗法识别出独特的瘤新抗原,以创建量身定制的治疗方法,提高疗效和减少副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 个性化医疗是个性化的医疗.
背景情况:
- 黑色素瘤表现出显著的遗传异质性,需要个性化的治疗策略.
- 目前的疗法往往缺乏特异性,导致潜在的非目标效应.
- 新抗原导向疗法通过向独特的瘤突变提供了个性化的方法.
研究的目的:
- 审查针对黑色素瘤的个性化新抗原导向治疗背后的逻辑.
- 总结目前针对黑色素瘤治疗的个性化新抗原疫苗的进展.
主要方法:
- 鉴定患者特异性免疫原性新抗原 (突变蛋白).
- 开发治疗性疫苗 (或RNA) 编码已识别的新抗原.
- 结合新抗原疫苗与免疫检查点抑制剂的临床试验.
主要成果:
- 新抗原疫苗的目的是诱导针对癌细胞的特定免疫反应.
- 个性化治疗显示出减少副作用和提高疗效的潜力.
- 临床试验表明,当将新抗原疫苗与免疫检查点抑制剂相结合时,有希望的结果.
结论:
- 个性化新抗原导向治疗是一种有希望的,针对黑色素瘤的量身定制方法.
- 进一步的研究和临床试验对于优化这种个性化治疗策略至关重要.
- 新抗原疫苗代表了黑色素瘤个性化治疗的重大进展.
相关概念视频
Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Cancer Vaccines
330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330


